Company / Shares Outstanding
Trevi Therapeutics, Inc. Shares Outstanding History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
102.0M
FY2024
5-year range
18.1M / 102.0M
FY2020-FY2024
Trend
+3.0%
vs FY2023
Sector context
#95 of 212
Health Care
What the data says
At 101971873.00, Trevi Therapeutics, Inc.'s shares outstanding ranks #118 of 212 in the Health Care sector. Shares Outstanding has increased for 6 consecutive years, from 437610.00 in FY2018 to 101971873.00 in FY2024.
Based on SEC 10-K filings.
101971873.00 in FY2024 with a 5-year CAGR of +54.1%.
Increased from 64541911.00 to 101971873.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +64.7%
- 5-Year CAGR
- +54.1%
- 10-Year CAGR
- -
Sector benchmark
#118 of 212 in Health CareTop 55% of 212This company 102.0M Sector average 306.7M
▼
-66.8% below sector average
Key checks
Key Insights
- Trevi Therapeutics, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2024, shares outstanding increased 3.0% year-over-year.
- Ranks #95 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 102.0M | +3.0% |
| FY2023 | 99.0M | +53.4% |
| FY2022 | 64.5M | +182.6% |
| FY2021 | 22.8M | +26.5% |
| FY2020 | 18.1M | +53.9% |
| FY2019 | 11.7M | +2581.8% |
| FY2018 | 437.6K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026